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Abstract:	  	   Idiopathic	  pulmonary	  fibrosis	  (IPF)	  is	  characterized	  by	  a	  significant	  increase	  in	  collagen	  deposits	  in	  lung	  extracellular	  matrix	  (ECM)	  compared	  to	  non-­‐IPF	  patients.	  Excessive	  collagen	  deposition	  is	  essential	  to	  the	  pathology	  of	  IPF	  and	  affects	  the	  fibrotic	  response	  to	  injury	  in	  lung	  tissue.	  Collagen	  turnover	  is	  regulated	  by	  autophagy,	  an	  intracellular	  mechanism	  that	  involves	  lysosomal	  degradation	  of	  unnecessary	  or	  dysfunctional	  cell	  components.	  It	  has	  been	  reported	  that	  autophagy	  is	  unsuccessful	  despite	  pathway	  activation	  in	  lungs	  of	  IPF	  patients.	  Previous	  work	  demonstrated	  that	  combination	  treatment	  of	  IPF	  cell	  lines	  with	  5’-­‐aza-­‐2’-­‐deoxycytidine,	  a	  DNA	  methylatransferase	  inhibitor,	  and	  rapamycin,	  an	  mTOR	  inhibitor,	  restored	  expression	  of	  key	  autophagy-­‐regulating	  genes	  through	  decreased	  promoter	  CpG	  island	  methylation.	  Using	  primary	  lung	  fibroblasts	  from	  IPF	  patients	  and	  IPF	  fibroblast	  cell	  lines,	  we	  performed	  knockdown	  studies	  of	  each	  DNMT-­‐1,	  3A,	  and	  3B	  mRNAs.	  Initial	  results	  show	  a	  marked	  reduction	  of	  DNMT-­‐1	  mRNA	  (84%	  reduction	  in	  both	  normal	  and	  severe	  IPF	  fibroblasts),	  DNMT-­‐3A	  mRNA	  (68%	  reduction	  in	  normal	  fibroblasts	  relative	  to	  83%	  in	  severe	  fibroblasts),	  and	  DNMT-­‐3B	  mRNA	  (42%	  reduction	  in	  normal	  fibroblasts	  compared	  to	  49%	  in	  severe	  IPF	  fibroblasts).	  Interestingly,	  as	  a	  result,	  when	  comparing	  expression	  of	  the	  3	  key	  autophagy-­‐regulating	  genes	  BECN1,	  ATG5,	  and	  ATG12,	  it	  was	  targeting	  of	  DNMT-­‐3B,	  and	  not	  DNMT-­‐1	  as	  hypothesized,	  that	  increased	  expression	  of	  these	  autophagy	  genes.	  This	  data	  suggests	  that	  DNMT-­‐3B	  plays	  a	  regulatory	  role	  in	  restoring	  autophagy	  to	  IPF	  fibroblasts.	  In	  order	  to	  verify	  these	  data,	  we	  are	  currently	  investigating	  autophagy	  function	  in	  normal	  and	  IPF	  fibroblasts	  after	  siRNA	  targeting	  of	  DNMTs.	  Understanding	  the	  relationship	  between	  the	  functional	  responsibilities	  between	  DNA	  methylation	  moieties	  like	  DNMTs	  and	  histone	  deacetylases	  (HDACs),	  and	  their	  regulation	  of	  autophagy	  genes	  and	  function	  could	  identify	  new	  therapeutic	  targets	  for	  patients	  with	  IPF.	  	  
Introduction:	  	   The	  cause	  of	  Idiopathic	  Pulmonary	  Fibrosis	  (IPF)	  is,	  by	  definition,	  unknown.	  However,	  recent	  research	  has	  led	  a	  belief	  that	  IPF	  may	  be	  caused	  more	  by	  mechanisms	  representing	  aberrant	  wound	  healing	  more	  than	  chronic	  inflammation,	  which	  was	  previously	  thought	  to	  underlie	  the	  pathogenesis	  of	  IPF1.	  Most	  of	  the	  recent	  drug	  activities	  involve	  inhibiting	  uric	  acid	  levels	  and	  attempting	  to	  reduce	  excess	  collagen	  deposits	  in	  the	  lung	  extracellular	  matrix	  (ECM).	  The	  prevalence	  of	  the	  disease	  is	  high	  for	  a	  lung	  disease,	  as	  IPF	  represents	  the	  most	  common	  cause	  of	  death	  from	  any	  progressive	  lung	  disease1.	  	  	  	   My	  project	  focuses	  on	  mechanisms	  responsible	  for	  dysfunctional	  collagen	  turnover	  in	  IPF	  lungs	  and	  its	  importance	  in	  the	  pathology	  of	  the	  disease.	  As	  discussed	  above,	  one	  mechanism	  for	  successful	  collagen	  turnover	  is	  autophagy.	  It	  has	  been	  reported	  that,	  in	  lungs	  of	  IPF	  patients,	  functional	  autophagy	  is	  inhibited	  despite	  pathway	  activation3.	  Previous	  work	  by	  the	  Marsh	  laboratory	  showed	  that	  multiple	  autophagy	  genes	  (ATG5,	  ATG12,	  LC3-­‐I,	  LC3-­‐II)	  were	  hypermethylated	  
(excessive	  promoter	  CpG	  island	  methylation)	  in	  IPF	  lung	  samples	  compared	  to	  samples	  from	  non-­‐IPF	  lungs.	  At	  the	  same	  time,	  it	  has	  been	  shown	  that	  DNA	  methyltransferases	  (DNMTs)	  are	  significantly	  overexpressed	  in	  IPF	  lungs,	  with	  an	  unclear	  relationship	  to	  autophagy.	  This	  led	  us	  to	  hypothesize	  that	  excessive	  DNMT	  activity	  was	  repressing	  autophagy-­‐related	  gene	  expression,	  activation	  of	  autophagy	  function,	  and	  ultimately	  collagen	  turnover.	  We	  hypothesized	  that	  knockdown	  of	  specific	  DNMTs	  by	  siRNA	  targeting	  may	  restore	  autophagy-­‐related	  gene	  expression	  and	  function	  in	  IPF	  fibroblast	  cell	  lines	  reflecting	  autophagy	  function	  essential	  for	  healthy	  lung	  function.	  	  	  
Methodology:	  	  
	  
Gene	  expression:	  To	  assay	  mRNA	  expression,	  total	  RNA	  was	  collected	  from	  normal	  and	  IPF	  fibroblast	  cell	   lines	   by	   TRIzol,	   synthesized	   into	   cDNA	   using	   SuperScript	   III	   Reverse	  Transcriptase	   from	   Life	   Technologies	   and	   subsequently	   quantified	   by	   qRT-­‐PCR.	  mRNA	  expression	   for	   all	   genes	   between	   samples	  were	   compared	   to	   housekeeping	  genes	  CAP1	  and	  RPL4.	  	  
DNA	  methylation:	  To	  assay	  for	  DNA	  promoter	  CpG	  island	  methylation,	  genomic	  DNA	  was	  isolated	  and	  quantified	  using	  the	  EpiTect	  II	  DNA	  methylation	  kit.	  	  
Autophagosome	  formation:	  To	   show	  autophagosome	   formation,	   cells	  were	   immunostained	  with	  DAPI	   (for	   cell	  nuclei)	  and	  GFP	  (specifically	   targeting	  autophagic	  vacuoles)	  and	   imaged	   through	  a	  live	  imaging	  microscope.	  	  
Protein	  expression:	  For	   protein	   expression	   of	   autophagy	   genes,	   samples	   were	   subjected	   to	   gel	  electrophoresis	  transfer	  and	  immunoblotted	  with	  specific	  antibodies.	  	  
Primary	  fibroblasts	  and	  fibroblast	  cell	  lines:	  Cell	   lines	   were	   acquired	   from	   the	   ATTC	   (American	   Type	   Culture	   Collection)	   and	  patients	  across	  the	  United	  States.	  	  
	  
Results:	  
	  Lung	  tissue	  from	  IPF	  patients	  have	  significantly	  reduced	  levels	  of	  key	  autophagy	  genes	  such	  as	  LC3-­‐I,	  LC3-­‐II,	  ATG5,	  and	  BECN1	  as	  compared	  to	  normal	  controls.	  	  	  
	  	  






Figure 1. Decreased autophagy gene expression in human IPF lung tissue 
compared to normal controls. Control (n=11), >80% FVC (n=8), 50-80% FVC 
(n=8) and <50% FVC (n=9), *p<0.005 compared to control tissue. This figure 
shows that IPF lung tissue, especially in its most severe form, has significantly 
lower autophagy gene expression than normal lung tissue in important 




Figure	  2.	  Decreased	  autophagy	  protein	  production	  in	  IPF	  patient	  lung	  tissue	  
compared	  to	  controls.	  n=2.	  Important	  autophagy	  genes	  ATG5	  and	  ATG12	  are	  shown	  to	  have	  significantly	  reduced	  protein	  expression	  as	  compared	  to	  normal	  controls.	  β-­‐Actin	  used	  as	  a	  loading	  control.	  	  	  With	  autophagy	  mRNA	  and	  protein	  levels	  significantly	  reduced	  in	  IPF	  lung	  samples,	  we	  hypothesized	  that	  DNA	  methylation	  may	  be	  one	  cause.	  	  	  	  





Figure 3. DNMTs transcription levels are altered in IPF lung tissue 
samples. (n=3 per severity group).  *p<0.005. Error bars consist of 
standard error. The more severe the type of IPF, the more DNMT is 
expressed. DNMT are DNA methyltransferases, and are the key 
enzymes involved in DNA methylation in the human body.  
	  	  
































Figure 4. Increased DNA methylation of autophagy-related gene 
promoters in human IPF lung tissue compared to control. (n=3 per 
severity group).  *p<0.005. Human IPF lung tissue is shown here to be much 
more methylated (>85%) than normal lung tissue. Shown here are the 
promoters of key autophagy genes, which are repressed by high levels of 































Figure 5. siRNA knockdown of DNMT-3B in normal lung fibroblasts (204) 
and severe IPF lung fibroblasts (191). Relative copy number (RCN) for 
DNMT-3B mRNA was calculated compared to housekeeping genes CAP1 and 
RPL4. Samples were then compared to a scrambled siRNA control (or no siRNA 
added) and the percentage of expression was determined. 
Figure 6. Autophagy gene expression with siRNA knockdown of DNMT-3B. 
204=black, 191=red. Autophagy gene expression from severe IPF fibroblast 
cell line (red) as compared to normal fibroblasts (black). Knocking down DNMT-
3B does not seem to effectively restore gene expression. 
	  	  
	  Due	  to	  these	  results,	  we	  thought	  it	  important	  to	  assay	  for	  baseline	  autophagy	  and	  DNMT	  mRNA	  levels	  in	  the	  cell	  lines	  as	  compared	  to	  the	  whole	  lung	  tissue	  samples	  (figure	  8).	  	  	  
Figure 7. Knockdown of DNMT-3B has minimaleffect on restoring 
autophagy function, in vitro. (n=3). Green fluorescence-represents 
autophagosome vesicle formation. Blue stain represents cell nuclei of 
fibroblasts. More green indicates more autophagy function. Quantification 
of green pixels in all images indicates no significant difference when cells 





























































Fibroblast	  Cell	  Lines	  
204	  (PDL=26.2)	  134	  (PDL=23.1)	  191	  (PDL=18)	  
Figure 8. Baseline mRNA expression for fibroblast cell lines. 
Differences in autophagy-related mRNAs expression between normal (204) 
and mild IPF fibroblasts (134) are larger than between normal and severe 
(191) (n=2). DNMTs mRNA expression is lower relative to IPF whole lung 
tissue levels. 
as	  well	  as	  not	  having	  any	  impact	  on	  increasing	  autophagy	  function	  (figures	  6,7).	  However,	  it	  is	  important	  to	  note	  the	  switch	  from	  human	  tissue	  (whole	  lung	  samples)	  to	  cell	  lines	  (fibroblast	  cell	  lines)	  in	  these	  experiments.	  One	  possible	  explanation	  for	  the	  unexpected	  differences	  between	  whole	  lung	  tissue	  samples	  and	  in	  vitro	  cell	  lines	  is	  the	  age	  of	  the	  cells.	  Aging	  is	  known	  to	  increase	  the	  incidence	  of	  IPF	  with	  over	  two	  thirds	  of	  patients	  with	  the	  disease	  over	  the	  age	  of	  601.	  Senescence,	  or	  the	  cellular	  state	  in	  which	  cells	  no	  longer	  respond	  to	  growth	  factor	  stimuli,	  is	  also	  known	  to	  increase	  with	  age4.	  Biomarkers	  for	  senescence	  include	  the	  tumor	  suppressor	  gene	  p16	  and	  telomere	  length.	  It	  is	  possible	  that	  the	  cells	  used	  for	  the	  experiments	  simply	  were	  not	  old	  enough	  to	  replicate	  the	  results	  of	  the	  tissue,	  which	  come	  from	  older	  patients	  in	  severe	  stages	  of	  the	  disease.	  Preliminary	  results	  (data	  not	  shown)	  illustrate	  a	  relatively	  greater	  reduction	  in	  autophagy	  gene	  expression	  in	  older	  cells	  than	  their	  younger	  counterparts,	  along	  with	  a	  higher	  amount	  of	  DNA	  methyltransferase	  (DNMT)	  expression.	  However,	  this	  change	  is	  not	  nearly	  dramatic	  enough	  to	  account	  for	  the	  nearly	  10-­‐fold	  difference	  in	  expression	  levels	  between	  the	  tissue	  samples	  and	  the	  cell	  lines.	  Future	  studies	  will	  need	  to	  be	  performed	  to	  investigate	  why	  the	  cell	  lines	  seem	  to	  have	  different	  baseline	  levels	  than	  their	  tissue	  counterparts.	  For	  example,	  although	  we	  achieved	  42	  and	  48%	  reduction	  in	  the	  expression	  of	  DNMT-­‐3B	  mRNA	  in	  the	  normal	  and	  IPF	  fibroblast	  cell	  lines,	  autophagy	  gene	  expression	  was	  not	  completely	  restored	  to	  normal	  levels.	  We	  elected	  to	  utilize	  cell	  lines	  for	  knockout	  studies	  to	  demonstrate	  functional	  relevance	  and	  causation	  in	  a	  complete	  system.	  These	  experiments	  cannot	  be	  performed	  on	  frozen	  or	  fixed	  tissue	  in	  lung	  patient	  samples.	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